Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis

  • STATUS
    Recruiting
  • End date
    Apr 24, 2025
  • participants needed
    75
  • sponsor
    University of Wisconsin, Madison
Updated on 24 July 2022
MRI
Accepts healthy volunteers

Summary

The overall purpose of this research is to determine whether new macromolecular measures optimized for whole brain (gray matter and white matter) magnetic resonance imaging (MRI), predict neuro-cognitive impairment in multiple sclerosis (MS) patients.

Description

MRI is a vital component of a MS work-up, providing noninvasive evidence of MS lesions, detecting active inflammatory lesions, and measuring brain atrophy to assess neurodegeneration. Recent years of MRI research have generated strong evidence of gray matter (GM) involvement in MS, resulting in the reclassification of MS as a whole-brain disease. Similar to white matter (WM), a primary target of MS pathology in GM is myelin, the protective sheath insulating the penetrating axons within GM and extending brain connectivity all the way to the neuronal bodies.

This aim of this research is to examine if the associations between imaging measures of GM disease and cognitive performance can establish GM-based imaging correlates predicting the disease course and accurately assessing treatment results.

This observational research will enroll adults diagnosed with MS both with and without cognitive impairment. Subjects will be asked to complete a single research visit that includes the administration of a MRI scan and a neuro-cognitive testing session.

Details
Condition Multiple Sclerosis, MS
Treatment MRI, Neuropsychological testing
Clinical Study IdentifierNCT04415372
SponsorUniversity of Wisconsin, Madison
Last Modified on24 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Clinically definite MS
Adult age 18 to 60

Exclusion Criteria

Contraindication to MRI
Changes in MS therapy in the last 6 months
Less than 6 weeks after relapse or corticosteroid use
Currently taking medication that may affect cognition (e.g. donepezil, rivastigmine, adderall)
History of significant alcohol or drug abuse
Current or recent significant migraines
Confounding neurological or cognitive disorders or deficits (stroke, Parkinson's disease, Alzheimer's disease, epilepsy)
Sensory or physical impairments that might interfere significantly with cognitive testing
History of developmental or learning disability or attention-deficit/hyperactivity disorder.\
Exclusion Criteria for Healthy Controls
history of alcohol/drug abuse
history of migraines
developmental or learning disability/attention-deficit/hyperactivity disorder
currently pregnant/breastfeeding
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note